LIMINAL BIOSCIENCES - Trademark Details
Status: 700 - Registered
Serial Number
79293279
Registration Number
6422386
Word Mark
LIMINAL BIOSCIENCES
Status
700 - Registered
Status Date
2021-07-20
Filing Date
2020-04-17
Registration Number
6422386
Registration Date
2021-07-20
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260502, 260513, 260516, 261701, 261704 - Plain single line triangles. Two Triangles. Triangles touching or intersecting. Straight line(s), band(s) or bar(s). Vertical line(s), band(s) or bar(s).
Published for Opposition Date
2021-05-04
Attorney Name
Law Office Assigned Location Code
L70
Employee Name
THOMAS, JULIE
Statements
Indication of Colors claimed
The color(s) teal, light green and gray is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"BIOSCIENCES"
Description of Mark
The mark consists of two interlocking incomplete triangles in gradients of teal and light green to the left of a vertical gray line and the wording "LIMINAL BIOSCIENCES" in gray. The color white represents background and is not a feature of the mark.
Goods and Services
Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of asthma; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the treatment of brain diseases and disorders, namely, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; pharmaceutical preparations for the treatment of dandruff; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; anti-viral agents; antibiotics; antivirals; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders; pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue; pharmaceutical preparations for the treatment of drug and alcohol abuse; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely, infertility, sexually transmitted diseases, incontinence and sexual dysfunction; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of glaucoma; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hypercholesterolemia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of metabolic disorders, namely, diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of motion sickness; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of myalgia and neuralgia; pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's disease, cerebral palsy; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident, stroke, Parkinson's disease, multiple sclerosis, myasthenia gravis
Goods and Services
Manufacture of pharmaceuticals to the order and specification of others
Goods and Services
Development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research and development; pharmaceutical research services; research on the subject of pharmaceuticals
Goods and Services
Pharmaceutical advice; pharmaceutical consultancy services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing information to patients in the field of administering medications; medical care services relating to patient treatment, excluding services in the field of psychology and mental health
Goods and Services
Providing personal support services for families of patients with life threatening disorders, namely, emotional counseling and emotional support, and coordinating the procurement and administration of medication; providing companionship services for families of patients with life threatening disorders
Pseudo Mark
LIMINAL BIOSCIENCES
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-09-11
Primary Code
005
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2020-09-11
Primary Code
040
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-09-11
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-09-11
Primary Code
044
International Class
045 - Personal and social services rendered by others to meet the needs of individuals; security services for the protection of property and individuals. - Personal and social services rendered by others to meet the needs of individuals; security services for the protection of property and individuals.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-09-11
Primary Code
045
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (incorporated company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (incorporated company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (incorporated company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (incorporated company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Timothy H. Hiebert
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1549453
International Registration Date
2020-04-17
International Publication Date
2020-09-10
International Renewal Date
2030-04-17
Auto Protection Date
2022-03-10
International Status
001 - Request for extension of protection established
International Status Date
2020-09-10
Priority Claimed In
True
Priority Claimed Date
2019-10-17
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2020-09-10 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2020-09-11 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2020-09-11 | ASSIGNED TO EXAMINER |
| 2020-09-12 | NON-FINAL ACTION WRITTEN |
| 2020-09-13 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2020-09-15 | APPLICATION FILING RECEIPT MAILED |
| 2020-09-30 | REFUSAL PROCESSED BY MPU |
| 2020-10-01 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2020-10-19 | REFUSAL PROCESSED BY IB |
| 2021-03-21 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-03-21 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-03-22 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-03-29 | EXAMINERS AMENDMENT -WRITTEN |
| 2021-03-29 | EXAMINERS AMENDMENT E-MAILED |
| 2021-03-29 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2021-03-29 | EXAMINER'S AMENDMENT ENTERED |
| 2021-03-29 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-04-14 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-04-14 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2021-04-14 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2021-05-02 | NOTIFICATION PROCESSED BY IB |
| 2021-05-04 | PUBLISHED FOR OPPOSITION |
| 2021-05-04 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-07-20 | REGISTERED-PRINCIPAL REGISTER |
| 2021-10-20 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 2021-11-26 | FINAL DISPOSITION PROCESSED |
| 2021-11-26 | FINAL DISPOSITION NOTICE SENT TO IB |
| 2021-12-26 | FINAL DECISION TRANSACTION PROCESSED BY IB |
